GM2-41503-87922 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-08
Dose 1 — Janssen/Johnson & Johnson
2021-09-09
Registered in v-safe
2021-09-09
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Poor · Headache, Nausea

Adult check-in
2021-09-10
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-09-11
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-09-12
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-09-13
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-09-14
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-09-15
Health check-in — day 7, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-09-22
Survey response — day 14, dose 1, dependent
MedDRA: Urticaria — Feeling: Poor · Be unable to work or attend school

Free text: Massive hives

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-08	Janssen/Johnson & Johnson	No

Free text

Release 9 — day 14, dose 1, dependent

2021-09-22

Symptoms: Massive hives

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release